Literature DB >> 25218344

MiR-124 represses vasculogenic mimicry and cell motility by targeting amotL1 in cervical cancer cells.

Hai-Ying Wan1, Qin-Qin Li2, Yan Zhang1, Wei Tian1, Ya-Nan Li2, Min Liu1, Xin Li1, Hua Tang3.   

Abstract

miRNAs have extensive functions in differentiation, metabolism, programmed cell death, and tumor metastasis by post-transcriptional regulation. Vasculogenic mimicry is an important pathway in tumor metastasis. Many factors can regulate vasculogenic mimicry, including miRNAs. In previous studies, miR-124 was found to repress proliferation and metastasis in different types of cancers, but whether it functions in cervical cancer remained unknown. Here, we demonstrate that miR-124 can repress vasculogenic mimicry, migration and invasion in HeLa and C33A cells in vitro. Furthermore, we reveal that the effect of miR-124 on vasculogenic mimicry, migration and invasion results from its interaction with AmotL1. MiR-124 regulates AmotL1 negatively by targeting its 3'untranslated region (3'UTR). We found that miR-124 can repress the EMT process. Together, these results improve our understanding of the function of miR-124 in tumor metastasis and will help to provide new potential target sites for cervical cancer treatment.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  AmotL1; Cervical cancer cells; EMT; Vasculogenic mimicry; miR-124

Mesh:

Substances:

Year:  2014        PMID: 25218344     DOI: 10.1016/j.canlet.2014.09.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  44 in total

1.  Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells.

Authors:  Zhong-Dong Wang; Fan-Yong Qu; Yuan-Yuan Chen; Zhang-Shen Ran; Hai-Yan Liu; Hai-Dong Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2017 Jan.       Impact factor: 3.066

2.  miR-519d-3p Inhibits Cell Proliferation and Invasion of Gastric Cancer by Downregulating B-Cell Lymphoma 6.

Authors:  Yong-Yuan Li; Jian-Ping Shao; Shu-Peng Zhang; Guo-Qiang Xing; Hong-Jie Liu
Journal:  Cytogenet Genome Res       Date:  2018-03-07       Impact factor: 1.636

3.  LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p.

Authors:  Min Zhang; Yinghui Song; Lijuan Yu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

4.  miR-124 represses FZD5 to attenuate P-glycoprotein-mediated chemo-resistance in renal cell carcinoma.

Authors:  Qing-Zhi Long; Yue-Feng Du; Xiao-Gang Liu; Xiang Li; Da-Lin He
Journal:  Tumour Biol       Date:  2015-04-12

5.  Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer.

Authors:  Shouru Zhang; Zhongxue Fu; Jinlai Wei; Jinbao Guo; Maoxi Liu; Kunli Du
Journal:  Med Oncol       Date:  2014-12-04       Impact factor: 3.064

6.  C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer.

Authors:  Xi Yang; Yaqi Hu; Yankun Liu; Weiying Liu; Xiaoqing Zhao; Min Liu; Hua Tang
Journal:  Mol Cell Biochem       Date:  2017-04-28       Impact factor: 3.396

7.  MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.

Authors:  Shikai Liu; Lili Song; Saitian Zeng; Liang Zhang
Journal:  Tumour Biol       Date:  2015-08-05

Review 8.  The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer.

Authors:  Yaheng Li; Chuanyin Li; Shuyuan Liu; Jia Yang; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

9.  MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1.

Authors:  Yan Zhou; Yanzhen Han; Zhitao Zhang; Zhe Shi; Liyuan Zhou; Xiaohong Liu; Xiaoyan Jia
Journal:  Hum Cell       Date:  2016-10-14       Impact factor: 4.374

10.  NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10.

Authors:  Yingjia Sun; Xinghao Ai; Shengping Shen; Shun Lu
Journal:  Oncotarget       Date:  2015-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.